Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takuji Mizushima is active.

Publication


Featured researches published by Takuji Mizushima.


Journal of Clinical Microbiology | 2001

Clinical Relevance of the babA2 Genotype of Helicobacter pylori in Japanese Clinical Isolates

Takuji Mizushima; Toshiro Sugiyama; Yoshito Komatsu; Jyun Ishizuka; Mototsgu Kato; Masahiro Asaka

ABSTRACT Genotypic variation of Helicobacter pylori is speculated to associate with different clinical outcomes. In Western countries, the gene encoding blood group antigen-binding adhesin (BabA), babA2, is of high clinical relevance and is a useful marker to identify patients who are at higher risk for peptic ulceration and gastric adenocarcinoma, as are vacA andcagA. We investigated the presence of babA2 andcagA in 179 Japanese clinical isolates by PCR and Southern blot analysis and looked for correlations with various clinical outcomes (nonulcer dyspepsia, duodenal ulcers, gastric ulcers gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma). The prevalence of the babA2 genotype was 84.9% and that of thecagA genotype was 96.1%. There was no correlation between the babA2 and cagA genotypes, and there was no association between the babA2 or cagA status and clinical outcome. These results indicate that babA2status is not of high clinical relevance in Japan and that Japanese strains are different from those infecting Western populations.


Helicobacter | 2002

The Relationship Between Consumption of Antimicrobial Agents and the Prevalence of Primary Helicobacter pylori Resistance

L. Perez Aldana; Mototsugu Kato; Souichi Nakagawa; M. Kawarasaki; T. Nagasako; Takuji Mizushima; Hisashi Oda; Junichi Kodaira; Yuichi Shimizu; Yoshito Komatsu; R. Zheng; Hiroshi Takeda; T. Sugiyama; Masahiro Asaka

Background. Primary and acquired resistance to the antimicrobial agents is a primary reason for the failure of Helicobacter pylori eradication therapies. We assessed the primary antibiotic resistance rates of H. pylori to three different antibiotics and its relationship due to the annual antibiotic consumption in Japan during the period prior to approval of anti‐H. pylori therapy in Japan.


Alimentary Pharmacology & Therapeutics | 2001

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism

Kaku Hokari; T. Sugiyama; Mototsugu Kato; M. Saito; Takuto Miyagishima; Mineo Kudo; K. Nishikawa; Jyun Ishizuka; Yoshito Komatsu; Takuji Mizushima; Hidetoshi Kagaya; Shuhei Hige; Hiroshi Takeda; Masahiro Asaka

Rabeprazole is a new, potent, proton pump inhibitor. The metabolism of rabeprazole is less dependent on CYP2C19 genetic polymorphism.


Journal of Biological Chemistry | 2003

Up-regulated Smad5 mediates apoptosis of gastric epithelial cells induced by Helicobacter pylori infection.

Tomokazu Nagasako; Toshiro Sugiyama; Takuji Mizushima; Yosuke Miura; Mototsugu Kato; Masahiro Asaka

The gastric pathogen Helicobacter pylori activates epithelial cell signaling pathways, and its infection induces changes in the expression of several genes in infected human gastric tissues. Recent studies have indicated that the ability of H. pylori to regulate epithelial cell responses depends on the presence of an intact cag pathogenicity island (cagPAI). We investigated altered mRNA expression of gastric epithelial cells after infection with H. pylori, both cagPAI-positive and cagPAI-negative strains, by cDNA microarray, reverse transcription PCR, and Northern blot analysis. Our results indicated that cagPAI-positive H. pylori strains (ATCC 43504 and clinical isolated strains) significantly activated Smad5 mRNA expression of human gastric epithelial cells (AGS, KATOIII, MKN28, and MKN45). We further examined whether the up-regulated Smad5 was related to apoptosis of gastric epithelial cells induced byH. pylori. Smad5 RNA interference completely inhibitedH. pylori-induced apoptosis. These results suggest that Smad5 is up-regulated in gastric epithelial cells through the presence of cagPAI of H. pylori and that Smad5 mediates apoptosis of gastric epithelial cells induced by H. pyloriinfection.


Alimentary Pharmacology & Therapeutics | 2000

High-dose ecabet sodium improves the eradication rate of Helicobacter pylori in dual therapy with lansoprazole and amoxicillin

Hidetoshi Kagaya; Mototsugu Kato; Yoshito Komatsu; Takuji Mizushima; Makoto Sukegawa; K. Nishikawa; Kaku Hokari; Hiroshi Takeda; T. Sugiyama; Masahiro Asaka

The additive effect of ecabet sodium in combination with dual therapy on Helicobacter pylori eradication was evaluated.


Digestive Diseases and Sciences | 2001

Attributable Risk of H. pylori in Peptic Ulcer Disease

Toshiro Sugiyama; K. Nishikawa; Yoshito Komatsu; Jyun Ishizuka; Takuji Mizushima; Ayae Kumagai; Mototsugu Kato; Nagahito Saito; Hiroshi Takeda; Masahiro Asaka; James W. Freston

Recent reports in the United States have found that fewer peptic ulcers are due to Helicobacter pylori than previously believed. The aim of this study is to determine if the declining prevalence of H. pylori infection in the general population can account for the apparent increase in the frequency of non-H. pylori ulcers. A total of 396 patients with peptic ulcer or ulcer scar were enrolled in this study. The pre-1950 population consisted of 149 patients with gastric ulcers and with 44 duodenal ulcers. The post-1950 population consisted of 96 patients with gastric ulcers and 107 with duodenal ulcers. The frequency of H. pylori-negative gastric ulcers was 5.4% in patients born before 1950 and 4.2% in patients born after 1950, and the frequency of H. pylori-negative duodenal ulcers was 0% and 1.9%, respectively. There are no statistical differences between the two populations in gastric and duodenal ulcers. H. pylori seropositivity was 74.9% in asymptomatic volunteers born before 1950 and 20.7% in those born after 1950 (P < 0.01) in the general population. The attributable risk of H. pylori infection in peptic ulcer diseases was not affected by the prevalence of H. pylori infection in the general population in Japan. This suggests that the apparent increase in frequency of non-H. pylori ulcers in the United States is not simply due to the declining prevalence of infection. Other explanations for non-H. pylori ulcers should be sought.


Helicobacter | 2002

Decreased Adherence of cagG‐DeletedHelicobacter pylori to Gastric Epithelial Cells in Japanese Clinical Isolates

Takuji Mizushima; Toshiro Sugiyama; Takahiko Kobayashi; Yoshito Komatsu; Mototsugu Kato; Masahiro Asaka

Background. The cag pathogenicity island (cag PAI) is a major virulence factor. The ability of Helicobacter pylori to adhere to gastric epithelial cells is an important initial step for virulence. The aim of this study was to evaluate the relationship between genetic variations of cag PAI in Japanese clinical isolates and the ability of H. pylori to adhere to gastric epithelial cells.


Digestive Diseases and Sciences | 2001

Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?

Toshiro Sugiyama; K. Nishikawa; Yoshito Komatsu; Jyun Ishizuka; Takuji Mizushima; Ayae Kumagai; Mototsugu Kato; Nagahito Saito; Hiroshi Takeda; Masahiro Asaka; James W. Freston


Gastroenterology | 2000

Assessmentof Helicobacter pylori eradication using a Urine-based elisa of anti-Helicobacter pyloriantibody

Mototsugu Kato; Kaku Hokari; Takuji Mizushima; Makoto Sukegawa; Yoshito Komatsu; Hidetoshi Kagaya; K. Nishikawa; Hiroshi Takeda; Toshiro Sugiyama; Masahiro Asaka


Gastroenterology | 2001

H. Pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection of early gastric cancer

Mototsugu Kato; Kaku Hokari; Takuji Mizushima; Yoshito Komatsu; Souichi Nakagawa; Hidetoshi Kagaya; Toshiro Sugiyama; Masahiro Asaka

Collaboration


Dive into the Takuji Mizushima's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge